SightfileU.S. market data from official filings
Companies › ALVO
ALVOTECH (ALVO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001898416 · EDGAR filings · Updated 2026-07-01
ALVOTECH (ALVO) has reported institutional ownership of 5.4%, with 57 institutional managers holding positions valued at $57.3M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Institutional ownership
5.4%
Institutional managers
57
Reported 13F value
$57.3M
Data flags
1 active
from SEC filings
Latest updates
- 2026-07-01 — Foreign issuer report (6-K) filed
- 2026-06-30 — SCHEDULE 13D/A filed
- 2026-06-18 — Foreign issuer report (6-K) filed
- 2026-06-17 — Foreign issuer report (6-K) filed
- 2026-06-16 — Prospectus supplement (424B5) filed
- 2026-06-16 — FWP filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ALVOTECH has 57 institutional holders and institutional ownership of 5.4%.
Data flags from SEC filings
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2024-03-20 (recurring since 2023-03-01) — source filing. The authoritative details are those stated in the filing itself.
Related companies
AVITA MEDICAL INC (RCEL) · NEURONETICS INC (STIM) · ALPHA COGNITION INC (ACOG) · LAKELAND INDUSTRIES INC (LAKE) · OUTSET MED INC (OM) · MDXHEALTH SA (MDXH)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.